UPMC Hillman Cancer Center at Butler Health System
Butler, Pennsylvania, United States
Cancer treatment center in Butler County, Pennsylvania
129 Oneida Valley Rd Suite 311, Butler, PA 16001
About UPMC Hillman Cancer Center at Butler Health System
"UPMC Hillman Cancer Center at Butler Health System (Medical Oncology) is a cancer treatment center located in Butler.Visit our website to learn more about the conditions we treat and the services we offer. Schedule your appointment today. UPMC is committed to protecting our communities from the spread of COVID-19. We continue to require people who come to any UPMC facility to wear a facemask that covers their nose and mouth and to practice other preventative efforts like social distancing, even if fully vaccinated."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
6
ECOG-ACRIN Cancer Research Group
2
Alliance for Clinical Trials in Oncology
1
SWOG Cancer Research Network
1
Clinical Trials at UPMC Hillman Cancer Center at Butler Health System
During the past decade, UPMC Hillman Cancer Center at Butler Health System conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
2014-08-18
Recruiting
8,300
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
2014-08-18
2036-05-01
Recruiting
168
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
2015-08-12
2025-12-31
Active, not recruiting
6,452
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
2017-09-12
2024-04-02
Active, not recruiting
700
Nivolumab and Ipilimumab in Treating Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma Undergoing Surgery
2019-01-17
2023-12-31
Suspended
278
Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer
2020-05-01
2025-12-31
Recruiting
327
CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy
2020-02-11
2038-12-31
Recruiting
2,156
Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents
2021-04-28
2023-12-15
Active, not recruiting
164
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "UPMC Hillman Cancer Center at Butler Health System"
#1 collaborator was "National Cancer Institute (NCI)" with 4 trials as a collaborator and "NRG Oncology" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at UPMC Hillman Cancer Center at Butler Health System
According to Clinical.Site data, the most researched conditions in "UPMC Hillman Cancer Center at Butler Health System" are
"ALK Gene Rearrangement" (1 trials), "ALK Gene Translocation" (1 trials), "ALK Positive" (1 trials), "Advanced Lung Non-Small Cell Carcinoma" (1 trials) and "Advanced Malignant Solid Neoplasm" (1 trials). Many other conditions were trialed in "UPMC Hillman Cancer Center at Butler Health System" in a lesser frequency.
Clinical Trials Intervention Types at UPMC Hillman Cancer Center at Butler Health System
Most popular intervention types in "UPMC Hillman Cancer Center at Butler Health System" are "Drug" (10 trials), "Biological" (7 trials), "Procedure" (7 trials), "Other" (5 trials) and "Radiation" (2 trials). Other intervention types were less common.
The name of intervention was led by "Computed Tomography" (6 trials), "Magnetic Resonance Imaging" (4 trials), "Paclitaxel" (4 trials), "Biospecimen Collection" (3 trials) and "Carboplatin" (3 trials). Other intervention names were less common.
Clinical Trials Genders at UPMC Hillman Cancer Center at Butler Health System
The vast majority of trials in "UPMC Hillman Cancer Center at Butler Health System" are
9 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at UPMC Hillman Cancer Center at Butler Health System
Currently, there are NaN active trials in "UPMC Hillman Cancer Center at Butler Health System".
undefined are not yet recruiting,
6 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in UPMC Hillman Cancer Center at Butler Health System,
1 suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in UPMC Hillman Cancer Center at Butler Health System, 0 "Phase 1"
clinical trials were conducted, 7 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".